Atlas Trials

The Safety and Efficacy Study of HU-014 Versus Botox® in Subject With Moderate to Severe Glabellar Lines

Clinical trial NCT02961673 · COMPLETED

Trial details

NCT number
NCT02961673
Sponsor
Huons Co., Ltd.
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Glabellar Lines
Start date
2016-09-01
Primary completion
2017-02-01
Enrollment
57

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.